Solid Tumors

Oncology·MeSH: Brain Neoplasms

505 drugs in development·199 companies·64 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
lymphoseek kit	Cardinal Health Inc. (CAH)
pedmark	FENNEC PHARMACEUTICALS INC. (FENC)
tevimbra	BeOne Medicines Ltd. (ONC)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(86)

Drug	Company
Alectinib	ENANTA PHARMACEUTICALS INC (ENTA)
avelumab	GH Research PLC (GHRS)
Avelumab	Merck & Co., Inc. (MRK)
Avelumab	Merus N.V. (MRUS)
azd3470	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
cetuximab	Incyte Corp. (INCY)
Cetuximab	BeOne Medicines Ltd. (ONC)
chemotherapy	Incyte Corp. (INCY)
chemotherapy	SPECTRUM PHARMACEUTICALS INC (SPPI)
chemotherapy	BeOne Medicines Ltd. (ONC)
Chemotherapy	ARS Pharmaceuticals, Inc. (SPRY)
Chemotherapy	BeOne Medicines Ltd. (ONC)
Divarasib	ENANTA PHARMACEUTICALS INC (ENTA)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
Entrectinib	ENANTA PHARMACEUTICALS INC (ENTA)
epacadostat	Incyte Corp. (INCY)
ERAS-0015 in combination	Erasca, Inc. (ERAS)
ERAS-4001 in combination	Erasca, Inc. (ERAS)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
FLOT	AGENUS INC (AGEN)
FOLFIRI-HD	IGM Biosciences, Inc. (IGMS)
folfox	Incyte Corp. (INCY)
Four week alternating FOLFOX and FOLFIRI	IGM Biosciences, Inc. (IGMS)
hmpl-a251	HUTCHMED (China) Ltd (HMDCF)
hmpl-a580	HUTCHMED (China) Ltd (HMDCF)
hmpl-a580	HUTCHMED (China) Limited (HCM)
horse anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
HS-20117 combined HS-20093 and 5-FU	IGM Biosciences, Inc. (IGMS)
HS-20117 combined Platinum-containing chemotherapy	IGM Biosciences, Inc. (IGMS)
HS-20117+FOLFIRI	IGM Biosciences, Inc. (IGMS)
HS-20117+mFOLFOX6	IGM Biosciences, Inc. (IGMS)
inca00186	Incyte Corp. (INCY)
inca036873	Incyte Corp. (INCY)
inca33890	Incyte Corp. (INCY)
incb0123667	Incyte Corp. (INCY)
incb081776	Incyte Corp. (INCY)
incb106385	Incyte Corp. (INCY)
incb161734	Incyte Corp. (INCY)
incb177054	Incyte Corp. (INCY)
incb186748	Incyte Corp. (INCY)
incmga00012	Incyte Corp. (INCY)
Ipatasertib	ENANTA PHARMACEUTICALS INC (ENTA)
IV Rilvegostomig	ASTRAZENECA PLC (AZN)
JDQ443	Novartis AG (NVS)
Lartesertib	Merck & Co., Inc. (MRK)
Lazertinib	ENANTA PHARMACEUTICALS INC (ENTA)
LY3537982	ELI LILLY & Co (LLY)
MEDI4736	ASTRAZENECA PLC (AZN)
mfolfirinox	Incyte Corp. (INCY)
MK-0472	Merck & Co., Inc. (MRK)
MK-1084	Merck & Co., Inc. (MRK)
MK-3120	Merck & Co., Inc. (MRK)
MK-4280	Merck & Co., Inc. (MRK)
MK-4280	Merus N.V. (MRUS)
MK-4280A	Merus N.V. (MRUS)
MK-4280A	Merck & Co., Inc. (MRK)
mRNA-4359	Moderna, Inc. (MRNA)
Naporafenib	Erasca, Inc. (ERAS)
Other Combination Anti-Cancer Therapies	ENANTA PHARMACEUTICALS INC (ENTA)
Pemetrexed	BRISTOL MYERS SQUIBB CO (BMY)
pertuzumab	ENANTA PHARMACEUTICALS INC (ENTA)
Pertuzumab IV	ENANTA PHARMACEUTICALS INC (ENTA)
rabbit anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
retifanlimab	Incyte Corp. (INCY)
SC Rilvegostomig	ASTRAZENECA PLC (AZN)
SC rilvegostomig + rHu	ASTRAZENECA PLC (AZN)
surzebiclimab	BeOne Medicines Ltd. (ONC)
tak-102	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-188	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-188	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-505	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-505	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-981	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-981	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tebentafusp	Immunocore Holdings plc (IMCR)
tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	BeOne Medicines Ltd. (ONC)
Trametinib	Erasca, Inc. (ERAS)
Trametinib	Novartis AG (NVS)
tsr-042	TESARO, Inc. (TSRO)
zl-1310	Zai Lab Ltd (ZLAB)
zoldonrasib	REVOLUTION MEDICINES, INC. (RVMD)

Phase 2(66)

Drug	Company
ACR-2316	Acrivon Therapeutics, Inc. (ACRV)
agen2373	AGENUS INC (AGEN)
alks 4230	Mural Oncology plc (MURA)
Amivantamab	ENANTA PHARMACEUTICALS INC (ENTA)
apl-101	Apollomics Inc. (APLM)
Belvarafenib	ENANTA PHARMACEUTICALS INC (ENTA)
BGB-53038	BeOne Medicines Ltd. (ONC)
BMS-986249	CytomX Therapeutics, Inc. (CTMX)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
Calcium folinate	BRISTOL MYERS SQUIBB CO (BMY)
Camonsertib	ENANTA PHARMACEUTICALS INC (ENTA)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
carbon nanoparticle iron	NYMOX PHARMACEUTICAL CORP (NYMXF)
Cediranib	Merus N.V. (MRUS)
Cediranib	ADMA BIOLOGICS, INC. (ADMA)
Cediranib	ASTRAZENECA PLC (AZN)
crolibulin	IMMUNE PHARMACEUTICALS INC (IMNP)
cyt-0851	Cyteir Therapeutics, Inc. (CYT)
daraxonrasib	BRISTOL MYERS SQUIBB CO (BMY)
Direct Oral Anticoagulant	Structure Therapeutics Inc. (GPCR)
eflapegrastim	SPECTRUM PHARMACEUTICALS INC (SPPI)
Eflapegrastim	ARS Pharmaceuticals, Inc. (SPRY)
eganelisib	INFINITY PHARMACEUTICALS, INC. (INFI)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
exosting	Codiak BioSciences, Inc. (CDAK)
fpi-2059	Fusion Pharmaceuticals Inc. (FUSN)
gen-009	GENOCEA BIOSCIENCES, INC. (GNCA)
gomekli	SpringWorks Therapeutics, Inc. (SWTX)
IMP321	Immutep Limited (IMMP)
imx-110	Immix Biopharma, Inc. (IMMX)
incb057643	Incyte Corp. (INCY)
incb059872	Incyte Corp. (INCY)
incb086550	Incyte Corp. (INCY)
incb099280	Incyte Corp. (INCY)
incb099318	Incyte Corp. (INCY)
Interleukin-2	Filana Therapeutics Inc. (FLNA)
iph4502	Innate Pharma S.A. (IPHA)
jtx-8064	Jounce Therapeutics, Inc. (JNCE)
kb-0742	Kronos Bio, Inc. (KRON)
LEE011	Novartis AG (NVS)
Lenvatinib	Merus N.V. (MRUS)
leucovorin	Mirati Therapeutics, Inc. (MRTX)
Leucovorin	FATE THERAPEUTICS INC (FATE)
mm-121	MERRIMACK PHARMACEUTICALS INC (MACK)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
nazartinib	Novartis AG (NVS)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
osimertinib	Novartis AG (NVS)
pc14586	PMV Pharmaceuticals, Inc. (PMVP)
Pemetrexed	Structure Therapeutics Inc. (GPCR)
Pemetrexed	FATE THERAPEUTICS INC (FATE)
Pralsetinib	ENANTA PHARMACEUTICALS INC (ENTA)
rad101	Radiopharm Theranostics Limited (RADX)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
seribantumab	Elevation Oncology, Inc. (ELEV)
snk02	NKGen Biotech, Inc. (NKGN)
solnerstotug	Sensei Biotherapeutics, Inc. (SNSE)
sotigalimab	Apexigen, Inc. (APGN)
SRK-181	Scholar Rock Holding Corp (SRRK)
tislelizumab	Novartis AG (NVS)
tislelizumab	Novartis AG (NVS)
trametinib	Novartis AG (NVS)
trc102	Tracon Pharmaceuticals, Inc. (TCON)
Tuvusertib	Merck & Co., Inc. (MRK)

Phase 1(191)

Drug	Company
[14c] subasumstat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
[14c] subasumstat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
177lu-pnt6555	POINT Biopharma Global Inc. (PNT)
a small molecular multi-target kinase inhibitor	UNITED THERAPEUTICS Corp (UTHR)
AB521	EXELIXIS, INC. (EXEL)
ABBV-181	AbbVie Inc. (ABBV)
ABBV-368	AbbVie Inc. (ABBV)
Abiraterone	BioNTech SE (BNTX)
abtl-0812	SCICLONE PHARMACEUTICALS INC (SCLN)
adagrasib	Incyte Corp. (INCY)
adxs-her2	OLD AYALA, INC (AYLA)
ADXS-HER2 (ADXS31-164)	Ayala Pharmaceuticals, Inc. (ADXS)
amg 355	AMGEN INC (AMGN)
amg 410	AMGEN INC (AMGN)
amg 436	AMGEN INC (AMGN)
amg 510	AMGEN INC (AMGN)
an9025	Adlai Nortye Ltd. (ANL)
Anti-PD-1 monoclonal antibody	iTeos Therapeutics, Inc. (ITOS)
anti-thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
Anticancer agent	iTeos Therapeutics, Inc. (ITOS)
APR-1051	Aprea Therapeutics, Inc. (APRE)
arq 751	ARQULE INC (ARQL)
ASP1570	IGM Biosciences, Inc. (IGMS)
atrc-101	Atreca, Inc. (BCEL)
ATRN-119	Aprea Therapeutics, Inc. (APRE)
aube00	CASI Pharmaceuticals, Inc (DE) (CASI)
Avelumab	Immutep Limited (IMMP)
bg-89894	BeOne Medicines Ltd. (ONC)
BG-89894	BeOne Medicines Ltd. (ONC)
bg-c0902	BeOne Medicines Ltd. (ONC)
BG-C0902	BeOne Medicines Ltd. (ONC)
bg-c477	BeOne Medicines Ltd. (ONC)
BG-C477	BeOne Medicines Ltd. (ONC)
BG-C477	Merus N.V. (MRUS)
BGB-53038	ENANTA PHARMACEUTICALS INC (ENTA)
BGB-B455	Merus N.V. (MRUS)
bgm-2121	PRECISION BIOSCIENCES INC (DTIL)
BI 1831169	ENANTA PHARMACEUTICALS INC (ENTA)
bi-1206	CASI Pharmaceuticals, Inc (DE) (CASI)
blu-222	Blueprint Medicines Corp (BPMC)
BP1001-A	BIO-PATH HOLDINGS, INC. (BPTH)
brenetafusp	Immunocore Holdings plc (IMCR)
Brenetafusp and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and kinase inhibitors	Immunocore Holdings plc (IMCR)
Brenetafusp and monoclonal antibodies and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and tebentafusp	Immunocore Holdings plc (IMCR)
cabozantinib	Kura Oncology, Inc. (KURA)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
cetuximab	C4 Therapeutics, Inc. (CCCC)
cetuximab	CASI Pharmaceuticals, Inc (DE) (CASI)
CFT1946	C4 Therapeutics, Inc. (CCCC)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
CLN-418	Cullinan Therapeutics, Inc. (CGEM)
CLN-617	Cullinan Therapeutics, Inc. (CGEM)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
CLR 121225	Cellectar Biosciences, Inc. (CLRB)
cna3103	Neuphoria Therapeutics Inc. (NEUP)
CT-0508	Carisma Therapeutics Inc. (CARM)
CT-0525	Carisma Therapeutics Inc. (CARM)
CT-1119	Carisma Therapeutics Inc. (CARM)
CT-202	Context Therapeutics Inc. (CNTX)
CX-904	CytomX Therapeutics, Inc. (CTMX)
darlifarnib	Kura Oncology, Inc. (KURA)
day301	Day One Biopharmaceuticals, Inc. (DAWN)
DB-1311	KYNTRA BIO INC. (KYNB)
dcr-pdl1	Dicerna Pharmaceuticals Inc (DRNA)
dcvax-direct	NORTHWEST BIOTHERAPEUTICS INC (NWBO)
DS6051b	Nuvation Bio Inc. (NUVB)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
elzovantinib	Turning Point Therapeutics, Inc. (TPTX)
Enzalutamide	BioNTech SE (BNTX)
EO-3021	Elevation Oncology, Inc. (ELEV)
EO-3021 (also known as SYSA1801 or CPO102)	Elevation Oncology, Inc. (ELEV)
EOS006215	iTeos Therapeutics, Inc. (ITOS)
EOS301984	iTeos Therapeutics, Inc. (ITOS)
ERAS-0015	Erasca, Inc. (ERAS)
ERAS-007	Erasca, Inc. (ERAS)
ERAS-12	Erasca, Inc. (ERAS)
ERAS-3490	Erasca, Inc. (ERAS)
ERAS-4	Erasca, Inc. (ERAS)
ERAS-4001	Erasca, Inc. (ERAS)
ERAS-601	Erasca, Inc. (ERAS)
etigilimab	OncoMed Pharmaceuticals Inc (OMED)
felezonexor	STEMLINE THERAPEUTICS INC (STML)
FID-022	Fulgent Genetics Inc. (FLGT)
folfiri	Incyte Corp. (INCY)
fpi-1966	Fusion Pharmaceuticals Inc. (FUSN)
fpt155	FIVE PRIME THERAPEUTICS, INC. (FPRX)
gemnabp	Incyte Corp. (INCY)
gen1057	Genmab A/S (GMAB)
gen1079	Genmab A/S (GMAB)
gen1106	Genmab A/S (GMAB)
gl-onc1	GENELUX Corp (GNLX)
gs-1811	Jounce Therapeutics, Inc. (JNCE)
gs-2121	GILEAD SCIENCES, INC. (GILD)
gs-9911	GILEAD SCIENCES, INC. (GILD)
hbm4003	Q BioMed Inc. (QBIO)
hro761	Novartis AG (NVS)
hro761	NOVARTIS AG (NVSEF)
HS-20117 combined HS-20093	IGM Biosciences, Inc. (IGMS)
HS-20117+CAPEOX	IGM Biosciences, Inc. (IGMS)
IDE-161	IDEAYA Biosciences, Inc. (IDYA)
IDE275 (GSK959)	IDEAYA Biosciences, Inc. (IDYA)
IDE705 (GSK101)	IDEAYA Biosciences, Inc. (IDYA)
im-1340	Immunome Inc. (IMNM)
im-3050	Immunome Inc. (IMNM)
IMC-R117C (PIWIL-1)	Immunocore Holdings plc (IMCR)
imgc936	ImmunoGen, Inc. (IMGN)
IMGC936	MACROGENICS INC (MGNX)
IMP321	Merus N.V. (MRUS)
Interleukin-2	Merus N.V. (MRUS)
itraconazole	KYNTRA BIO INC. (KYNB)
kin-2787	KINNATE BIOPHARMA INC. (KNTE)
KSQ-001EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	Merus N.V. (MRUS)
KSQ-004EX	Filana Therapeutics Inc. (FLNA)
KT-253	Kymera Therapeutics, Inc. (KYMR)
KT-333	Kymera Therapeutics, Inc. (KYMR)
Lopinavir and Ritonavir Tablets	BioNTech SE (BNTX)
loxo-292	LOXO ONCOLOGY, INC. (LOXO)
MGC028	MACROGENICS INC (MGNX)
MK-1484	SUTRO BIOPHARMA, INC. (STRO)
mnpr-101-lu	Monopar Therapeutics (MNPR)
mnpr-101-zr	Monopar Therapeutics (MNPR)
MRG007	ArriVent BioPharma, Inc. (AVBP)
MT-304	ENANTA PHARMACEUTICALS INC (ENTA)
mt-6402	Molecular Templates, Inc. (MTEM)
nana-val	Viracta Therapeutics, Inc. (VIRX)
narazaciclib	TRAWS PHARMA, INC. (ONTX)
ngm438	NGM BIOPHARMACEUTICALS INC (NGM)
ngm831	NGM BIOPHARMACEUTICALS INC (NGM)
NK Cell Infusion	Filana Therapeutics Inc. (FLNA)
NT-I7	Merck & Co., Inc. (MRK)
NUV-868	KYNTRA BIO INC. (KYNB)
oncr-177	Oncorus, Inc. (ONCR)
panitumumab	AMGEN INC (AMGN)
pf-8046052	LAVA Therapeutics NV (LVTX)
pimivalimab	Jounce Therapeutics, Inc. (JNCE)
PLN-101095	PLIANT THERAPEUTICS, INC. (PLRX)
plogosertib (plogo)	Bio Green Med Solution, Inc. (BGMSP)
premedication	Genmab A/S (GMAB)
prn1371	Principia Biopharma Inc. (PRNB)
promitil	Rafael Holdings, Inc. (RFL)
pt-112	SCICLONE PHARMACEUTICALS INC (SCLN)
qtx3034	QUANTA INC (QNTA)
qtx3544	QUANTA INC (QNTA)
Rabbit Anti thymocyte globulin	ENANTA PHARMACEUTICALS INC (ENTA)
Recombinant Human Hyaluronidase	ASTRAZENECA PLC (AZN)
rhIL-15	Filana Therapeutics Inc. (FLNA)
rmc-5552	REVOLUTION MEDICINES, INC. (RVMD)
RP-6306	IGM Biosciences, Inc. (IGMS)
rxdx-105	Ignyta, Inc. (RXDX)
S095035	Tango Therapeutics, Inc. (TNGX)
sim0505	NextCure, Inc. (NXTC)
sl-801	STEMLINE THERAPEUTICS INC (STML)
sl-901	STEMLINE THERAPEUTICS INC (STML)
sqz-pbmc-hpv	SQZ Biotechnologies Co (SQZB)
ST101	Janux Therapeutics, Inc. (JANX)
ST101	Royalty Pharma plc (RPRX)
ST101	Myovant Sciences Ltd. (MYOV)
ST101	Merus N.V. (MRUS)
ST101	PTC THERAPEUTICS, INC. (PTCT)
subasumstat	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
subasumstat	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
sy-5609	Syros Pharmaceuticals, Inc. (SYRS)
TAK-188	Merus N.V. (MRUS)
taladegib	Ignyta, Inc. (RXDX)
tbs-2025	TuHURA Biosciences, Inc./NV (HURA)
tcellvax	Regen BioPharma Inc (RGBPP)
tcrt-eso-a2	Athenex, Inc. (ATNX)
Temozolomide	Janux Therapeutics, Inc. (JANX)
Temozolomide	Royalty Pharma plc (RPRX)
Temozolomide	Myovant Sciences Ltd. (MYOV)
tev-56278	Teva Pharmaceutical Industries Limited (TEVA)
Tilsotolimod	AbbVie Inc. (ABBV)
tislelizumab	Q BioMed Inc. (QBIO)
tln-372	IGM Biosciences, Inc. (IGMS)
tln-372 in combination with cetuximab	IGM Biosciences, Inc. (IGMS)
toripalimab	Q BioMed Inc. (QBIO)
tpx-0046	Turning Point Therapeutics, Inc. (TPTX)
trametinib	C4 Therapeutics, Inc. (CCCC)
Trifluridine + Tipiracil	IGM Biosciences, Inc. (IGMS)
tsr-022	TESARO, Inc. (TSRO)
XB010	EXELIXIS, INC. (EXEL)
XmAb808	Xencor Inc (XNCR)
xmt-2056	Mersana Therapeutics, Inc. (MRSN)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
zl-6201	Zai Lab Ltd (ZLAB)
zw191	Zymeworks Inc. (ZYME)

Preclinical(84)

Drug	Company
244c8	ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM)
388d4	ENUMERAL BIOMEDICAL HOLDINGS, INC. (ENUM)
Aarvik ADC program	ArriVent BioPharma, Inc. (AVBP)
adp-520	Adaptimmune Therapeutics PLC (ADAP)
adp-600	Adaptimmune Therapeutics PLC (ADAP)
aktx-101	Akari Therapeutics Plc (AKTX)
Allogeneic CAR T cell therapy	Intellia Therapeutics, Inc. (NTLA)
allogeneic mait cell therapy	Pluri Inc. (PLUR)
Alpha-201 Macro1	Candel Therapeutics, Inc. (CADL)
apkci inhibitor	WINDTREE THERAPEUTICS INC /DE/ (WINT)
apn-346958	Atreca, Inc. (BCEL)
apn-497444	Atreca, Inc. (BCEL)
apvo451	Aptevo Therapeutics Inc. (APVO)
apvo603	Aptevo Therapeutics Inc. (APVO)
ba3142	BioAtla, Inc. (BCAB)
ba3361	BioAtla, Inc. (BCAB)
BP1003	BIO-PATH HOLDINGS, INC. (BPTH)
cab-nectin 4 x cab-cd3	BioAtla, Inc. (BCAB)
CBO421	Cidara Therapeutics, Inc. (CDTX)
chs-1000	Coherus Oncology, Inc. (CHRS)
CLD-400 (RTNova)	Calidi Biotherapeutics Inc. (CLDI)
cryptophycin-adc	Lantern Pharma Inc. (LTRN)
diffronc	Regen BioPharma Inc (RGBPP)
dnase-armored car t	Xenetic Biosciences, Inc. (XBIO)
duracar	Regen BioPharma Inc (RGBPP)
enLIGHTEN™ Discovery Platform (platform-level entry)	Candel Therapeutics, Inc. (CADL)
EO-1022	Elevation Oncology, Inc. (ELEV)
fpa157	FIVE PRIME THERAPEUTICS, INC. (FPRX)
fyarro + adagrasib	Whitehawk Therapeutics, Inc. (WHWK)
GPC3-targeted CAR T	CRISPR Therapeutics AG (CRSP)
gsk4381562	Coherus Oncology, Inc. (CHRS)
gtb-5550	GT Biopharma, Inc. (GTBP)
hcw11-018b	HCW Biologics Inc. (HCWB)
HER3-ADC (unnominated)	Elevation Oncology, Inc. (ELEV)
ifabotuzumab	HUMANIGEN, INC (HGEN)
im-1335	Immunome Inc. (IMNM)
inb-600	IN8BIO, INC. (INAB)
io112	IO Biotech, Inc. (IOBT)
io170	IO Biotech, Inc. (IOBT)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
jtx-1484	Jounce Therapeutics, Inc. (JNCE)
jtx-2134	Jounce Therapeutics, Inc. (JNCE)
kros 301	Kairos Pharma, LTD. (KAPA)
kva12123	TuHURA Biosciences, Inc./NV (HURA)
ladr 10	LadRx Corp (LADX)
ladr 7	LadRx Corp (LADX)
ladr 8	LadRx Corp (LADX)
ladr 9	LadRx Corp (LADX)
ladr-10	LadRx Corp (LADX)
ladr-7	LadRx Corp (LADX)
ladr-8	LadRx Corp (LADX)
ladr-9	LadRx Corp (LADX)
ladr10	LadRx Corp (LADX)
ladr7	LadRx Corp (LADX)
ladr8	LadRx Corp (LADX)
ladr9	LadRx Corp (LADX)
linebacker	IMPACT BIOMEDICAL INC. (IBO)
linebacker-1	IMPACT BIOMEDICAL INC. (IBO)
linebacker-2	IMPACT BIOMEDICAL INC. (IBO)
mait cells	Pluri Inc. (PLUR)
mapkapk2 inhibitor	METASTAT, INC. (MTST)
mdvac	Orgenesis Inc. (ORGS)
MGC030	MACROGENICS INC (MGNX)
mm-111	MERRIMACK PHARMACEUTICALS INC (MACK)
mnpr-101-ac	Monopar Therapeutics (MNPR)
Moderna development candidate - GPC3	Carisma Therapeutics Inc. (CARM)
neo-ptc-01	Neon Therapeutics, Inc. (NTGN)
nexi-005	NexImmune, Inc. (NEXI)
onc212	CHIMERIX INC (CMRX)
Pan-mutant BRAF degrader program (proprietary)	Nurix Therapeutics, Inc. (NRIX)
Pan-mutant BRAF program (mutant BRAF degraders)	Nurix Therapeutics, Inc. (NRIX)
pnt2004	POINT Biopharma Global Inc. (PNT)
pop1 program	Propanc Biopharma, Inc. (PPCB)
rt-ar001	REBUS HOLDINGS, INC. (NSPX)
rxdx-106	Ignyta, Inc. (RXDX)
rxdx-107	Ignyta, Inc. (RXDX)
sgr-3515	Schrodinger, Inc. (SDGR)
SNAP-CAR Platform	Coeptis Therapeutics Holdings Inc. (COEP)
t-loop	Orgenesis Inc. (ORGS)
tetra-specific antibody	OPKO HEALTH, INC. (OPK)
thor-707	Synthorx, Inc. (THOR)
trop2 adc	Peak Bio, Inc. (PKBO)
Undisclosed (Solid Tumors)	FATE THERAPEUTICS INC (FATE)
Unnamed enLIGHTEN™ candidate encoding IL-12 and IL-15	Candel Therapeutics, Inc. (CADL)

Unknown(7)

Drug	Company
Any other SSRI/SNRI not already specified	ENANTA PHARMACEUTICALS INC (ENTA)
CB-020	Caribou Biosciences, Inc. (CRBU)
Granulocyte colony-stimulating factor	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
HER-2 targeting ARC (CD47 combination program)	Actinium Pharmaceuticals, Inc. (ATNM)
HER3 targeting ARC	Actinium Pharmaceuticals, Inc. (ATNM)
HLX14	Organon & Co. (OGN)
Precise Tumor	MYRIAD GENETICS INC (MYGN)

BLA Filed(1)

Drug	Company
larotrectinib	LOXO ONCOLOGY, INC. (LOXO)

Phase 1/Phase 2(53)

Drug	Company
abiraterone	Incyte Corp. (INCY)
all-trans retinoic acid	Incyte Corp. (INCY)
anti pd-1/l1	AMGEN INC (AMGN)
bpx-603	BELLICUM PHARMACEUTICALS, INC (BLCM)
brimarafenib	SpringWorks Therapeutics, Inc. (SWTX)
cemiplimab	VERTEX PHARMACEUTICALS INC / MA (VRTX)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
cetuximab	Mirati Therapeutics, Inc. (MRTX)
cetuximab	Novartis AG (NVS)
cetuximab	AC Immune SA (ACIU)
chemotherapy	Oric Pharmaceuticals, Inc. (ORIC)
cpi-0209	CONSTELLATION PHARMACEUTICALS INC (CNST)
cr-001	CRESCENT BIOPHARMA, INC. (CBIO)
cr-002	CRESCENT BIOPHARMA, INC. (CBIO)
cr-003	CRESCENT BIOPHARMA, INC. (CBIO)
dcc-3116	Deciphera Pharmaceuticals, Inc. (DCPH)
envometinib	Immuneering Corp (IMRX)
gen1057	GENMAB A/S (GNMSF)
gen1079	GENMAB A/S (GNMSF)
gen1106	GENMAB A/S (GNMSF)
imc-r117c	Immunocore Holdings plc (IMCR)
iph4502	Innate Pharma SA (IPHYF)
Itraconazole	BioNTech SE (BNTX)
ivonescimab	REVOLUTION MEDICINES, INC. (RVMD)
jdq443	Novartis AG (NVS)
lee011	Novartis AG (NVS)
lp-184	Lantern Pharma Inc. (LTRN)
m9140	GH Research PLC (GHRS)
mdx2001	OPKO HEALTH, INC. (OPK)
mfolfox6	AC Immune SA (ACIU)
miransertib	ARQULE INC (ARQL)
monalizumab	AC Immune SA (ACIU)
nc762	NextCure, Inc. (NXTC)
olaparib	Incyte Corp. (INCY)
oral repotrectinib	Turning Point Therapeutics, Inc. (TPTX)
oral repotrectinib	TG THERAPEUTICS, INC. (TGTX)
oric-114	Oric Pharmaceuticals, Inc. (ORIC)
phase 1b	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
platinum-based doublet chemotherapy	VERTEX PHARMACEUTICALS INC / MA (VRTX)
platinum-based doublet chemotherapy	REGENERON PHARMACEUTICALS, INC. (REGN)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
regn7075	VERTEX PHARMACEUTICALS INC / MA (VRTX)
regn7075	REGENERON PHARMACEUTICALS, INC. (REGN)
rucaparib	Incyte Corp. (INCY)
slate	Gritstone bio, Inc. (GRTS)
sqz-eapc-hpv	SQZ Biotechnologies Co (SQZB)
tc-520	TCR2 THERAPEUTICS INC. (TCRR)
tno155	Novartis AG (NVS)
tno155	Novartis AG (NVS)
trifluridine-tipiracil	VERTEX PHARMACEUTICALS INC / MA (VRTX)
trifluridine-tipiracil	REGENERON PHARMACEUTICALS, INC. (REGN)
wtx-330	Werewolf Therapeutics, Inc. (HOWL)
XmAb662	Xencor Inc (XNCR)

Phase 2/Phase 3(6)

Drug	Company
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
eik1004	Eikon Therapeutics Inc. (EIKN)
eik1004-001	Eikon Therapeutics Inc. (EIKN)
eik1005	Eikon Therapeutics Inc. (EIKN)
tak-103	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)

Phase 4(7)

Drug	Company
axitinib	Incyte Corp. (INCY)
BAT8008 for Injection	Merus N.V. (MRUS)
bms-986484	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
mRNA-4157	Moderna, Inc. (MRNA)
nazartinib	NOVARTIS AG (NVSEF)
osimertinib	NOVARTIS AG (NVSEF)

Compare drugs

lymphoseek kit vs pedmark lymphoseek kit vs tevimbra lymphoseek kit vs zoledronic acid

Frequently asked questions

How many drugs are in development for Solid Tumors?

BioSniper tracks 505 drugs in development for Solid Tumors across 199 companies.

How many clinical trials target Solid Tumors?

There are 64 clinical trials targeting Solid Tumors tracked by BioSniper.

Deep-dive into Solid Tumors

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis